Skip to main content
. Author manuscript; available in PMC: 2015 Aug 20.
Published in final edited form as: Cancer Biol Ther. 2009 Nov 27;8(22):2186–2193. doi: 10.4161/cbt.8.22.10446

Figure 6. DLD1 cells show increased cytotoxicity to the combination of 5-FU and ellipticine as compared to treatment with either agent alone.

Figure 6

DLD1 cells were treated for 4 days with single agent or combination of 5-FU and ellipticine in 24 well plates. The concentrations in the x-axis are the concentrations of 5-FU and ellitpicine, respectively. Cell counts were determined by a hemocytometer and the numbers represent all the remaining cells in each particular well in the 24-well plate at the different treatment conditions.